Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study. (Q39068453)
Jump to navigation
Jump to search
scientific article published on 7 November 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study. |
scientific article published on 7 November 2016 |
Statements
Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study (English)
Edith A Perez
Carlos Barrios
Wolfgang Eiermann
Young-Hyuck Im
Miguel Martin
Howard Burris
Jennifer A Petersen
Sven Stanzel
Alexander Strasak
Monika Patre
1 reference